Immunology/Inflammation

The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-   B1643 Sodium 4-AminosalicylateSummary: NF-κB inhibitor B1643 Sodium 4-AminosalicylateSummary: NF-κB inhibitor
-   B1587 IMD 03541 CitationSummary: IKKβ inhibitor B1587 IMD 03541 CitationSummary: IKKβ inhibitor
-   N1315 ParthenolideTarget: Histone Deacetylases (HDACs)|MDM2|DNA Methyltransferases|p53|5-HT N1315 ParthenolideTarget: Histone Deacetylases (HDACs)|MDM2|DNA Methyltransferases|p53|5-HT
-   B1586 IKK-16 (IKK Inhibitor VII)1 CitationSummary: Selective IκB kinase inhibitor B1586 IKK-16 (IKK Inhibitor VII)1 CitationSummary: Selective IκB kinase inhibitor
-   C4107 N-3-oxo-dodecanoyl-L-Homoserine lactoneSummary: NF-κB and AP-2 activator C4107 N-3-oxo-dodecanoyl-L-Homoserine lactoneSummary: NF-κB and AP-2 activator
-   B1585 SC-514Summary: ATP-competitive IKK-2 inhibitor, orally active B1585 SC-514Summary: ATP-competitive IKK-2 inhibitor, orally active
-   C4074 PPM-18Summary: NF-κB inhibitor C4074 PPM-18Summary: NF-κB inhibitor
-   A4602 TPCA-12 CitationSummary: IKK-2 inhibitor,potent and selective A4602 TPCA-12 CitationSummary: IKK-2 inhibitor,potent and selective
-   C3559 NF-κB Activation Inhibitor IIISummary: NF-κB inhibitor C3559 NF-κB Activation Inhibitor IIISummary: NF-κB inhibitor
-   B7199 Withaferin A1 CitationSummary: Prevents NF-κB activation by inhibiting activation of IKKβ B7199 Withaferin A1 CitationSummary: Prevents NF-κB activation by inhibiting activation of IKKβ
